186 related articles for article (PubMed ID: 20636030)
1. Immune adjuvants in early life: targeting the innate immune system to overcome impaired adaptive response.
de Brito CA; Goldoni AL; Sato MN
Immunotherapy; 2009 Sep; 1(5):883-95. PubMed ID: 20636030
[TBL] [Abstract][Full Text] [Related]
2. The neonatal immune system: immunomodulation of infections in early life.
Futata EA; Fusaro AE; de Brito CA; Sato MN
Expert Rev Anti Infect Ther; 2012 Mar; 10(3):289-98. PubMed ID: 22397563
[TBL] [Abstract][Full Text] [Related]
3. The role of innate immune responses in autoimmune disease development.
Waldner H
Autoimmun Rev; 2009 Mar; 8(5):400-4. PubMed ID: 19162250
[TBL] [Abstract][Full Text] [Related]
4. Use of adjuvants for immunotherapy.
Circelli L; Tornesello M; Buonaguro FM; Buonaguro L
Hum Vaccin Immunother; 2017 Aug; 13(8):1774-1777. PubMed ID: 28604160
[TBL] [Abstract][Full Text] [Related]
5. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
Jasani B; Navabi H; Adams M
Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
[TBL] [Abstract][Full Text] [Related]
6. Heat-shock proteins as endogenous ligands building a bridge between innate and adaptive immunity.
Tamura Y; Torigoe T; Kukita K; Saito K; Okuya K; Kutomi G; Hirata K; Sato N
Immunotherapy; 2012 Aug; 4(8):841-52. PubMed ID: 22947010
[TBL] [Abstract][Full Text] [Related]
7. Innate and adaptive immune pathways to tolerance.
Thornton CA; Morgan G
Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
[TBL] [Abstract][Full Text] [Related]
8. Pattern recognition receptors and control of adaptive immunity.
Palm NW; Medzhitov R
Immunol Rev; 2009 Jan; 227(1):221-33. PubMed ID: 19120487
[TBL] [Abstract][Full Text] [Related]
9. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells.
Krumbiegel D; Zepp F; Meyer CU
Hum Immunol; 2007 Oct; 68(10):813-22. PubMed ID: 17961769
[TBL] [Abstract][Full Text] [Related]
10. [Vaccine adjuvant].
Aoshi T; Ishii KJ
Nihon Rinsho; 2011 Sep; 69(9):1547-53. PubMed ID: 21922751
[TBL] [Abstract][Full Text] [Related]
11. Mast cells in allergy: innate instructors of adaptive responses.
Stelekati E; Orinska Z; Bulfone-Paus S
Immunobiology; 2007; 212(6):505-19. PubMed ID: 17544835
[TBL] [Abstract][Full Text] [Related]
12. [Toll-like receptors: recognition receptors of the innate immune system and target structures for therapeutical intervention].
Kabelitz D
Med Monatsschr Pharm; 2012 Jul; 35(7):238-44. PubMed ID: 22852274
[TBL] [Abstract][Full Text] [Related]
13. From tolerance to autoimmunity: is there a risk in early life vaccination?
Goriely S; Goldman M
J Comp Pathol; 2007 Jul; 137 Suppl 1():S57-61. PubMed ID: 17548092
[TBL] [Abstract][Full Text] [Related]
14. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells from bench to bedside and back.
Adema GJ
Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
[TBL] [Abstract][Full Text] [Related]
16. Impact of innate and adaptive immunity on rejection and tolerance.
Kim IK; Bedi DS; Denecke C; Ge X; Tullius SG
Transplantation; 2008 Oct; 86(7):889-94. PubMed ID: 18852649
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells: bridging innate and adaptive immunity in atopic dermatitis.
Novak N; Koch S; Allam JP; Bieber T
J Allergy Clin Immunol; 2010 Jan; 125(1):50-9. PubMed ID: 20109736
[TBL] [Abstract][Full Text] [Related]
18. Adjuvants and autoimmunity.
Israeli E; Agmon-Levin N; Blank M; Shoenfeld Y
Lupus; 2009 Nov; 18(13):1217-25. PubMed ID: 19880572
[TBL] [Abstract][Full Text] [Related]
19. IFN-alpha in the generation of dendritic cells for cancer immunotherapy.
Santini SM; Lapenta C; Santodonato L; D'Agostino G; Belardelli F; Ferrantini M
Handb Exp Pharmacol; 2009; (188):295-317. PubMed ID: 19031032
[TBL] [Abstract][Full Text] [Related]
20. Drugs targeting Toll-like receptors.
Krishnan J; Lee G; Choi S
Arch Pharm Res; 2009 Nov; 32(11):1485-502. PubMed ID: 20091261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
